5 Results for "

MLL translocations

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "MLL translocations" in MCE Product Catalog:

Cat. No.: HY-132234
CAS No.: 2377337-93-2
Purity:  99.29%
Research Areas:  

Cancer

M‑1121 is a covalent and orally active inhibitor of the menin-MLL interaction capable of achieving complete and persistent tumor regression .
loading...
    loading...
Cat. No.: HY-153331
CAS No.: 2378768-36-4
Target:  

WDR5

Research Areas:  

Cancer

DDO-2213 is an orally active and potent WDR5-MLL1 inhibitor, with an IC50 of 29 nM and a Kd value of 72.9 nM for the WDR5 protein. DDO-2213 selectively inhibits MLL (mixed lineage leukemia) histone methyltransferase activity and the proliferation of MLL translocation-harboring cells. DDO-2213 can be used for MLL fusion leukemia research .
loading...
    loading...
Cat. No.: HY-141430
CAS No.: 2323623-80-7
Purity:  98.96%
Research Areas:  

Cancer

AS-85 is a potent ASH1L histone methyltransferase inhibitor (IC50=0.6 μM) with anti-leukemic activity. AS-85 strongly binds to the ASH1L SET domain, with the Kd value of 0.78 μM .
loading...
    loading...
Cat. No.: HY-117948A
CAS No.: 1560968-51-5
Research Areas:  

Cancer

(S)-ML399 (Compound 18S) is the enantiomer of ML399 (HY-117948). (S)-ML399 acts as a Menin-MLL interaction inhibitor with an IC50 of 1400 nM. (S)-ML399 can be used to investigate acute leukemias with MLL translocations, including acute myeloid leukemia and acute lymphoblastic leukemia .
loading...
    loading...
Cat. No.: HY-114699
CAS No.: 2001072-35-9
Target:  

Endogenous Metabolite

Research Areas:  

Cancer

DC_YM21 is an inhibitor of menin-MLL interaction with potent and selective proliferation blocking activity. DC_YM21 can induce cell cycle arrest and differentiation of leukemia cells carrying MLL translocation. DC_YM21 shows potential application value in inhibiting MLL leukemia .
loading...
    loading...